e-learning
resources
Berlin 2008
Tuesday, 07.10.2008
Recent advances in the treatment and pathogenesis of pulmonary diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cytokines status, endothelial function in patients with pulmonary diseases
N. V. Yahorava, I. S. Karpova, H. L. Hurevich, I. M. Lapteva, N. S. Shpakovskay (Minsk, Belarus)
Source:
Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases
Session:
Recent advances in the treatment and pathogenesis of pulmonary diseases
Session type:
E-Communication Session
Number:
4277
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. V. Yahorava, I. S. Karpova, H. L. Hurevich, I. M. Lapteva, N. S. Shpakovskay (Minsk, Belarus). Cytokines status, endothelial function in patients with pulmonary diseases. Eur Respir J 2008; 32: Suppl. 52, 4277
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Endothelial function in patients with pulmonary diseases
Source: Annual Congress 2008 - Imaging of different lung diseases: clinical and experimental observations
Year: 2008
Correction of endothelial dysfunction in patients with pulmonary diseases
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008
Role of IL-11 in vascular function of pulmonary fibrosis patients
Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Year: 2019
The role of pathological angiogenesis in the pathogenesis of the chronic inflammatory lung diseases
Source: Annual Congress 2005 - Update on the role of angiogenesis in the pathogenesis and treatment of lung diseases
Year: 2005
Growth factors and interleukin-6 across the lung circulation in pulmonary hypertension
Source: Eur Respir J 2009; 34: 662
Year: 2009
Systemic inflammation and endothelial dysfunction in patient with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 143s
Year: 2007
Genetic polymorphisms of inflammatory cytokines and endothelial dysfunction factors: role in patients with sarcoidosis
Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues
Year: 2019
Regulation of inflammation process in chronic thromboembolic pulmonary hypertension: a potential role of platelet-activating factor-acetylhydrolase
Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling
Year: 2006
Endothelial dysfunction in patients with occupational lung diseases
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010
Endothelial interactions of neutrophils under flow in chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 25: 612-617
Year: 2005
Prevalence and trafficking of circulating fibrocytes in smoking-related fibrogenic lung diseases
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Circulating endothelial progenitor cells and chronic pulmonary diseases
Source: Eur Respir J 2011; 37: 426
Year: 2011
Association between endothelial function and pulmonary function in patients with chronic obstructive pulmonary disease
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017
Determinants of endothelial function in patients with COPD
Source: Eur Respir J 2013; 42: 1194-1204
Year: 2013
Angiogenic activity of sera from patients with various types of pulmonary fibrosis in relation to pulmonary functions
Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation
Year: 2009
Transforming growth factor-β type II receptor in pulmonary arteries of patients with very severe COPD
Source: Eur Respir J 2006; 28: 556-562
Year: 2006
HIV-associated pulmonary arterial hypertension onset is associated with the soluble CD14 level and inflammation related to monocyte activation by LPS translocation from the gut
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
Inflammatory mediators contribute to pulmonary arterial cell dysfunction in a pulmonary arterial hypertension patient with
BMPR2
mutation
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013
Pulmonary hypertension: the science behind the disease spectrum
Source: Eur Respir Rev 2012; 21: 19-26
Year: 2012
Pulmonary hypertension and endothelial dysfunction in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 605s
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept